Development of T follicular helper cell-independent nanoparticle vaccines for SARS-CoV-2 or HIV-1 by targeting ICOSL.

IF 6.9 1区 医学 Q1 IMMUNOLOGY NPJ Vaccines Pub Date : 2024-09-28 DOI:10.1038/s41541-024-00971-4
Yongli Zhang, Achun Chen, Daiying Li, Quyu Yuan, Airu Zhu, Jieyi Deng, Yalin Wang, Jie Liu, Chaofeng Liang, Wenjie Li, Qiannan Fang, Jiatong Xie, Xiantao Zhang, Xu Zhang, Yiwen Zhang, Ran Chen, Ting Pan, Hui Zhang, Xin He
{"title":"Development of T follicular helper cell-independent nanoparticle vaccines for SARS-CoV-2 or HIV-1 by targeting ICOSL.","authors":"Yongli Zhang, Achun Chen, Daiying Li, Quyu Yuan, Airu Zhu, Jieyi Deng, Yalin Wang, Jie Liu, Chaofeng Liang, Wenjie Li, Qiannan Fang, Jiatong Xie, Xiantao Zhang, Xu Zhang, Yiwen Zhang, Ran Chen, Ting Pan, Hui Zhang, Xin He","doi":"10.1038/s41541-024-00971-4","DOIUrl":null,"url":null,"abstract":"<p><p>T helper cells, particularly T follicular helper (T<sub>FH</sub>) cells, are essential for the neutralizing antibody production elicited by pathogens or vaccines. However, in immunocompromised individuals, the inefficient support from T<sub>FH</sub> cells could lead to limited protection after vaccine inoculation. Here we showed that the conjugation of inducible T cell costimulatory (ICOS) onto the nanoparticle, together with immunogen, significantly enhanced the immune response of the vaccines specific for SARS-CoV-2 or human immunodeficiency virus type-1 (HIV-1) in T<sub>FH</sub>-deficient mice. Further studies indicated that ICOSL on B cells was triggered by ICOS binding, subsequently activated the PKCβ signaling pathway, and enhanced the survival and proliferation of B cells. Our findings revealed that the stimulation of ICOS-ICOSL interaction by adding ICOS on the nanoparticle vaccine significantly substitutes the function of T<sub>FH</sub> cells to support B cell response, which is significant for the immunocompromised people, such as the elderly or HIV-1-infected individuals.</p>","PeriodicalId":19335,"journal":{"name":"NPJ Vaccines","volume":null,"pages":null},"PeriodicalIF":6.9000,"publicationDate":"2024-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11438966/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Vaccines","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41541-024-00971-4","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

T helper cells, particularly T follicular helper (TFH) cells, are essential for the neutralizing antibody production elicited by pathogens or vaccines. However, in immunocompromised individuals, the inefficient support from TFH cells could lead to limited protection after vaccine inoculation. Here we showed that the conjugation of inducible T cell costimulatory (ICOS) onto the nanoparticle, together with immunogen, significantly enhanced the immune response of the vaccines specific for SARS-CoV-2 or human immunodeficiency virus type-1 (HIV-1) in TFH-deficient mice. Further studies indicated that ICOSL on B cells was triggered by ICOS binding, subsequently activated the PKCβ signaling pathway, and enhanced the survival and proliferation of B cells. Our findings revealed that the stimulation of ICOS-ICOSL interaction by adding ICOS on the nanoparticle vaccine significantly substitutes the function of TFH cells to support B cell response, which is significant for the immunocompromised people, such as the elderly or HIV-1-infected individuals.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
以 ICOSL 为靶点,开发不依赖 T 滤泡辅助细胞的纳米颗粒疫苗,用于治疗 SARS-CoV-2 或 HIV-1。
T辅助细胞,尤其是T滤泡辅助细胞(TFH),对于病原体或疫苗引起的中和抗体的产生至关重要。然而,在免疫力低下的个体中,TFH 细胞的低效支持可能会导致疫苗接种后的保护效果有限。在这里,我们发现在纳米颗粒上连接诱导性 T 细胞刺激因子(ICOS)和免疫原,能显著增强 TFH 缺陷小鼠对 SARS-CoV-2 或人类免疫缺陷病毒 1 型(HIV-1)特异性疫苗的免疫反应。进一步的研究表明,B 细胞上的 ICOSL 是由 ICOS 结合触发的,随后激活了 PKCβ 信号通路,并增强了 B 细胞的存活和增殖。我们的研究结果表明,在纳米颗粒疫苗中添加 ICOS 可刺激 ICOS-ICOSL 相互作用,从而显著替代 TFH 细胞支持 B 细胞应答的功能,这对免疫功能低下的人群(如老年人或 HIV-1 感染者)意义重大。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
NPJ Vaccines
NPJ Vaccines Immunology and Microbiology-Immunology
CiteScore
11.90
自引率
4.30%
发文量
146
审稿时长
11 weeks
期刊介绍: Online-only and open access, npj Vaccines is dedicated to highlighting the most important scientific advances in vaccine research and development.
期刊最新文献
CRISPR/Cas9 screens identify key host factors that enhance rotavirus reverse genetics efficacy and vaccine production. Leishmania tarentolae as a platform for the production of vaccines against viral pathogens. Regulatory review of benefits and risks of preventing infant RSV disease through maternal immunization. Safety, efficacy and immunogenicity of aerosolized Ad5-nCoV COVID-19 vaccine in a non-inferiority randomized controlled trial. High protection and transmission-blocking immunity elicited by single-cycle SARS-CoV-2 vaccine in hamsters.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1